TrialThoracic cancer2023

Development and validation of a nomogram based on preoperative variables for predicting recurrence-free survival in stage IA lung adenocarcinoma.

Jiaxi Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.